Literature DB >> 24697555

Impact of subject attrition on sample size determinations for longitudinal cluster randomized clinical trials.

Moonseong Heo1.   

Abstract

Subject attrition is a ubiquitous problem in any type of clinical trial and, thus, needs to be taken into consideration at the design stage particularly to secure adequate statistical power. Here, we focus on longitudinal cluster randomized clinical trials (cluster-RCT) that aim to test the hypothesis that an intervention has an effect on the rate of change in the outcome over time. In this setting, the cluster-RCT assumes a three-level hierarchical data structure in which subjects are nested within a higher level unit such as clinics and are evaluated for outcome repeatedly over the study period. Furthermore, the subject-specific slopes can be modeled in terms of fixed or random coefficients in a mixed-effects linear model. Closed-form sample size formulas for testing the preceding hypothesis have been developed under an assumption of no attrition. In this article, we propose closed-form approximate samples size determinations with anticipated attrition rates by modifying those existing sample size formulas. With extensive simulations, we examine performances of the modified formulas under three attrition mechanisms: attrition completely at random, attrition at random, and attrition not at random. In conclusion, the proposed modification is very effective under fixed-slope models but yields biased, perhaps substantially so, statistical power under random slope models.

Entities:  

Keywords:  Attrition; Effect size; Longitudinal cluster RCT; Power; Sample size; Three-level data

Mesh:

Year:  2014        PMID: 24697555      PMCID: PMC4034392          DOI: 10.1080/10543406.2014.888442

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  10 in total

1.  Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.

Authors:  C Ahn; S Tonidandel; J E Overall
Journal:  J Biopharm Stat       Date:  2000-05       Impact factor: 1.051

2.  Problematic formulations of SAS PROC.MIXED models for repeated measurements.

Authors:  J E Overall; C Ahn; C Shivakumar; Y Kalburgi
Journal:  J Biopharm Stat       Date:  1999-03       Impact factor: 1.051

3.  Sample size determination for hierarchical longitudinal designs with differential attrition rates.

Authors:  Anindya Roy; Dulal K Bhaumik; Subhash Aryal; Robert D Gibbons
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

4.  Sizing a trial to alter the trajectory of health behaviours: methods, parameter estimates, and their application.

Authors:  David M Murray; Jonathan L Blitstein; Peter J Hannan; William L Baker; Leslie A Lytle
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

5.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

6.  Remission in depressed geriatric primary care patients: a report from the PROSPECT study.

Authors:  George S Alexopoulos; Ira R Katz; Martha L Bruce; Moonseong Heo; Thomas Ten Have; Patrick Raue; Hillary R Bogner; Herbert C Schulberg; Benoit H Mulsant; Charles F Reynolds
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

7.  Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials with random slopes.

Authors:  Moonseong Heo; Xiaonan Xue; Mimi Y Kim
Journal:  Comput Stat Data Anal       Date:  2013-04-01       Impact factor: 1.681

8.  Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial.

Authors:  Allen J Dietrich; Thomas E Oxman; John W Williams; Herbert C Schulberg; Martha L Bruce; Pamela W Lee; Sheila Barry; Patrick J Raue; Jean J Lefever; Moonseong Heo; Kathryn Rost; Kurt Kroenke; Martha Gerrity; Paul A Nutting
Journal:  BMJ       Date:  2004-09-02

Review 9.  Design characteristics that influence attrition in geriatric antidepressant trials: meta-analysis.

Authors:  Moonseong Heo; Eros Papademetriou; Barnett S Meyers
Journal:  Int J Geriatr Psychiatry       Date:  2009-09       Impact factor: 3.485

10.  Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials.

Authors:  Moonseong Heo; Andrew C Leon
Journal:  Stat Med       Date:  2009-03-15       Impact factor: 2.373

  10 in total
  4 in total

Review 1.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

2.  Efficacy of a Community-Based Physical Activity Program KM2H2 for Stroke and Heart Attack Prevention among Senior Hypertensive Patients: A Cluster Randomized Controlled Phase-II Trial.

Authors:  Jie Gong; Xinguang Chen; Sijian Li
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

3.  Incidence of depressive symptoms among sexually abused children in Kenya.

Authors:  Teresia Mutavi; Anne Obondo; Donald Kokonya; Lincoln Khasakhala; Anne Mbwayo; Francis Njiri; Muthoni Mathai
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2018-07-30       Impact factor: 3.033

4.  The effect of missing data on design efficiency in repeated cross-sectional multi-period two-arm parallel cluster randomized trials.

Authors:  Mirjam Moerbeek
Journal:  Behav Res Methods       Date:  2021-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.